Subscribe to ExpertReview

The latest research, meeting updates and CME, in your inbox.

Hong Kong · Sponsored

Understanding the impact of unplanned psychotropic medication switches on patient outcomes

15 Jun 2023Neurology

Kathlin Ambrose

Share

This content is sponsored. It is intended for healthcare professionals only.

At a recent webinar co-organized by The Society of Hospital Pharmacists of Hong Kong and The Hong Kong College of Psychiatrists in collaboration with ZP Therapeutics, esteemed consultant psychiatrist and researcher Dr Howard C. Margolese spoke at length about important considerations when switching from branded to generic psychotropic medications.

MPR-ZUE-2022409 Symposium Highlight

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.

Log inRegister

Related posts

Stylized illustration of a large blue immune cell with surface receptors and yellow nuclei, surrounded by smaller cells.Research · OncologyESCAT v2 adds graded certainty tiers and a resistance scale for molecular targetsAn international ESMO expert panel has revised the 2018 ESCAT framework, restructuring Tier I, Tier II and Tier X, formalising tumour-agnostic gating criteria and adding a four-level scale for resistance biomarkers.8 Nov 2026